中国报告大厅网讯,随着精准诊疗需求的持续增长,核药作为现代医学的重要组成部分,在肿瘤诊断、靶向治疗等领域展现出独特优势。然而长期以来,国内医用同位素高度依赖进口,制约着行业创新步伐。在此背景下,远大医药加速推进战略布局,其成都温江核药基地即将于2025年6月正式运营,这一里程碑事件标志着中国在高端核药领域迈出关键一步。 一、构建全产业链闭环平台 引领核药研发新范式 中国报告大厅发布的《2025...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.